This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why Hold Strategy is Apt for Prudential Financial (PRU)
by Zacks Equity Research
Prudential Financial (PRU) stands to gain from higher emerging markets earnings, improved spread income, strategic acquisitions, effective capital deployment and a solid financial position.
Old Republic International (ORI) Is Up 1.29% in One Week: What You Should Know
by Zacks Equity Research
Does Old Republic International (ORI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Radian (RDN) Up 35% YTD: Should You Buy It for Better Return?
by Zacks Equity Research
Radian (RDN) is poised to gain from improving mortgage insurance portfolio, declining claims, the well-performing homegenius segment, a solid capital position and effective capital deployment.
Here's Why Hold Strategy Is Apt for Assurant (AIZ) Stock Now
by Zacks Equity Research
Assurant (AIZ) stands to gain from increasing Global Automotive business, higher average insured values, improved invested assets, favorable growth estimates and effective capital deployment.
MGIC Investment (MTG) Rises 31.6% YTD: More Room to Run?
by Zacks Equity Research
MGIC Investment (MTG) stock rallies on the back of higher insurance in force, a decline in loss and claims payments, better housing market fundamentals and a solid capital position.
Old Republic (ORI) Stock Rises 13.2% YTD: More Room to Grow?
by Zacks Equity Research
Solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and a strong capital position poise Old Republic (ORI) for growth.
Prudential (PRU), Warburg Pincus Form Prismic Life Reinsurance
by Zacks Equity Research
Prudential (PRU), Warburg Pincus and a group of investors form Prismic, which will have $10 billion initial reinsurance transaction and $1 billion equity capital investment.
Reasons Why Lemonade (LMND) Stock is an Attractive Pick Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from an improvement in continued shift in the mix of underlying products toward higher value policies and installment fees and a robust capital position.
Everest Group (EG) Stock Rises 10% YTD: More Upside Left?
by Zacks Equity Research
New business growth, strong renewal retention, continued favorable rate increases and a solid capital position continue to drive Everest Group (EG).
Should You Retain Voya Financial (VOYA) in Your Portfolio?
by Zacks Equity Research
Voya Financial (VOYA) stands to gain from higher investment income, lower fee-based margin, administrative expenses and prudent capital deployment.
Here's Why You Should Hold Prudential Financial (PRU) Stock
by Zacks Equity Research
Prudential Financial (PRU) stands to gain from higher premiums, strategic acquisitions, favorable underwriting results and effective capital deployment.
Why You Should Add Radian Group (RDN) Stock to Your Portfolio
by Zacks Equity Research
Radian Group (RDN) is well-poised to grow, driven by improved persistence, high investment income and a strong capital position.
MetLife (MET) Ventures Into Single Family Rental Space in the US
by Zacks Equity Research
MetLife's (MET) asset management arm, MetLife Investment Management, ventures into single-family rental space with a new fund, securing capital commitments of $390 million.
Old Republic (ORI) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
Although the revenue and EPS for Old Republic (ORI) give a sense of how its business performed in the quarter ended June 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Old Republic International (ORI) Q2 Earnings Beat Estimates
by Zacks Equity Research
Old Republic (ORI) delivered earnings and revenue surprises of 14.81% and 5.34%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Aegon (AEG) Closes Combination of Dutch Operations With a.s.r
by Zacks Equity Research
Aegon (AEG) is expected to commence a share repurchase program of EUR 1.5 billion over a year.
Mr. Cooper (COOP) Prolongs Tender Offer for Home Point Buyout
by Zacks Equity Research
Mr. Cooper (COOP) expects Home Point's outstanding 5% senior notes to serve as a low-cost funding source for the company.
MetLife (MET) Expands Partnership With DentalInsurance.com
by Zacks Equity Research
MetLife (MET) collaborates with DentalInsurance.com to provide impeccable service to customers purchasing dental health insurance.
AMERISAFE (AMSF) Jumps 6.9% in 3 Months: More Growth Ahead?
by Zacks Equity Research
AMERISAFE's (AMSF) shareholder-friendly moves are supported by a strong balance sheet with no debt, which provides plenty of financial flexibility.
AIG Rises 16.4% in Three Months: What's Driving the Stock?
by Zacks Equity Research
AIG's management is working on improving ROCE with the help of cost-curbing efforts, enhancing underwriting profitability and streamlining operations.
Here's Why Investors May Consider Betting on Assurant (AIZ) Now
by Zacks Equity Research
Assurant (AIZ) stands to gain from improved Connected Living business, well-diversified business, rise in invested assets, favorable growth estimates and a solid capital position.
Here's Why Investing in Lemonade (LMND) Stock is Prudent Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from growth on premium placed with third-party insurance companies, interest rates on investment balances and improvement in the average policy value.
Old Republic (ORI) Gains 16% in a Year: More Upside Left?
by Zacks Equity Research
Solid market presence, niche focus, low property catastrophe exposure in its General Insurance segment and solid capital position poise Old Republic (ORI) for growth.
Here's Why Hold Strategy is Apt for Coinbase Global (COIN)
by Zacks Equity Research
Coinbase Global (COIN) should benefit from an enhanced product suite and reduced operating expenses in the future.
Here's Why Investors Should Hold Cigna (CI) Stock for Now
by Zacks Equity Research
Cigna's (CI) strong Evernorth and Cigna Healthcare segments, growing medical membership and a positive 2023 outlook poise it well for growth.